Real-Time Continuous Glucose Monitoring in an Intensive Care Unit: Better Accuracy in Patients with Septic Shock
dc.contributor.author
dc.date.accessioned
2013-11-18T12:04:15Z
dc.date.available
2013-11-18T12:04:15Z
dc.date.issued
2012
dc.identifier.issn
1520-9156
dc.identifier.uri
dc.description.abstract
This study assessed the accuracy of real-time continuous glucose monitoring system (RTCGMS) devices in an intensive care unit (ICU) to determine whether the septic status of the patient has any influence on the accuracy of the RTCGMS. Subjects and methods: In total, 41 patients on insulin therapy were included. Patients were monitored for 72 h using RTCGMS. Arterial blood glucose (ABG) samples were obtained following the protocol established in the ICU. The results were evaluated using paired values (excluding those used for calibration) with the performance assessed using numerical accuracy. Nonparametric tests were used to determine statistically significant differences in accuracy. Results: In total, 956 ABG/RTCGMS pairs were analyzed. The overall median relative absolute difference (RAD) was 13.5%, and the International Organization for Standardization (ISO) criteria were 68.1%. The median RADs reported for patients with septic shock, with sepsis, and without sepsis were 11.2%, 14.3%, and 16.3%, respectively (P<0.05). Measurements meeting the ISO criteria were 74.5%, 65.6%, and 63.7% for patients with septic shock, with sepsis, and without sepsis, respectively (P<0.05). Conclusions: The results showed that the septic status of patients influenced the accuracy of the RTCGMS in the ICU. Accuracy was significantly better in patients with septic shock in comparison with the other patient cohorts
Aquest estudi avalua la precisió dels sistemes de monitorització contínua de glucosa a temps real (SMCG-TR) a una Unitat de Medicina Intensiva (UMI), per a determinar si l’estat sèptic dels pacients influencia en la seva precisió. 41 pacients van ser inclosos, monitoritzant-se durant 72h. La glucèmia arterial (GA) es va determinar simultàniament. Els resultats van ser avaluats utilitzant dades aparellades, obtenint-se 956 GA/SMCG-TR dades aparellades. Els resultats mostraren que l’estat sèptic dels pacients influencia sobre la precisió dels SMCG-TR. La precisió va ser significativament millor en aquells pacients crítics amb Xoc sèptic en comparació amb la resta de pacients
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
Mary Ann Liebert, Inc
dc.relation.isformatof
Reproducció digital del document publicat a: http://dx.doi.org/10.1089/dia.2012.0008
dc.relation.ispartof
© Diabetes Technology & Therapeutics, 2008, vol. 14, núm. 7, p. 568-575
dc.relation.ispartofseries
Articles publicats (IIIA)
dc.rights
Tots els drets reservats
dc.subject
dc.title
Real-Time Continuous Glucose Monitoring in an Intensive Care Unit: Better Accuracy in Patients with Septic Shock
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.embargo.terms
Cap
dc.type.version
info:eu-repo/semantics/publishedVersion
dc.identifier.doi
dc.identifier.idgrec
015967
dc.identifier.eissn
1557-8593